Myeloma and AL amyloidosis ASH 2024 previewAccess, AL amyloidosis, CAR-T, MPE, Myeloma29 November 2024
MPE webinar on ASH 2024 myeloma and AL amyloidosis highlightsAL amyloidosis, MPE, Myeloma, News29 November 2024
MPE provided feedback on the HTA Implementing Regulation on joint scientific consultations on medical devices and in vitro diagnostic medical devices at Union levelMPE, News27 November 2024
MPE comments on the European Medicines Agency’s policy on the handling of competing interests of scientific committees’ members and expertsMPE, News14 November 2024
During European Myeloma Day, MPE highlights the importance of improving access to clinical trialsAccess, MPE, Myeloma27 September 2024
MPE comments on the second implementing act of the EU health technology assessment (HTA) regulation (EU HTAR)Access, MPE26 June 2024
Watch the recording of webinar “AL amyloidosis treatment updates and patient experiences”AL amyloidosis, MPE24 April 2024
MPE launches the Myeloma and AL Amyloidosis European Clinical Trial NavigatorAccess, AL amyloidosis, MPE, Myeloma23 April 2024
